Authors

Jing Q. Cheng

Document Type

Patent

Publication Date

10-4-2016

Patent Number

9457040

CPC

A61K 31/7064 (20130101)

Abstract

The inventors have determined, contrary to the prior art and experience, how to successfully use triciribine to treat esophogeal adenocarcinoma by one or a combination of (i) administering triciribine only to patients which according to a diagnostic test described below, exhibit enhanced sensitivity to the drug; (ii) use of a described dosage level that minimizes the toxicity of the drug but yet still exhibits efficacy; or (iii) use of a described dosage regimen that minimizes the toxicity of the drug.

Application Number

14/832,400

Assignees

University of South Florida

Filing Date

2015-08-21

Share

COinS